Tom Lin, PhD, MS

Tom Lin – https://sites.rutgers.edu/tom-lin-lab/

PhD, Medicinal Chemistry, University of Tennessee HSC

MS, Natural Products, Peking University

BS, Pharmacy, Zhengzhou University

Postdoc, Chemical Proteomics, University of Pennsylvania,

Arginylation, Proteomics, Targeted Protein Degradation are the three major research topics.

1. Identify ATE1 substrates and their arginylation sites from human proteomes.
2. Elucidate the cellular functions of arginylation using cell and animal models.
3. Develop Arginylation Targeting Chimera (ArgTAC) degraders as novel therapeutics.

2025/03. NIH Grant Reviewer: CBP (Chemical Biology and Probes) Study Section.

2025/02. Washington University SURGE (Summer undergrad program) Admissions Committee member.

2024/11. Guest Advisor, Drug Delivery

2024/08. Guest Editor, Molecules

2024/01-2027/12. Editorial Board Member, Clinical Traditional Medicine and Pharmacology

2021/11-2023/12. Reviewer Editor, Clinical Complementary Medicine and Pharmacology

Google Scholar

ORCiD Page

2023/12          Active Reviewer Award, Clinical Complementary Medicine and Pharmacology (Elsevier)

2022/12          Outstanding Reviewer Award, Clinical Complementary Medicine and Pharmacology (Elsevier)

2018/03          University of Pennsylvania Regeneron Prize Nominee

2017/05          Robert A. Magarian Outstanding Podium Presentation Award, MALTO

2017/03          2016 National Award for Outstanding Self-financed Chinese Students Studying Abroad

2017/06          ACS Division of Medicinal Chemistry Travel Award

2016/10          Alma and Hal Reagan Fellowship, University of Tennessee HSC